Ignite Creation Date:
2025-12-25 @ 12:36 AM
Ignite Modification Date:
2026-02-20 @ 6:20 PM
Study NCT ID:
NCT02400567
Status:
COMPLETED
Last Update Posted:
2022-03-15
First Post:
2014-08-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy of Letrozole + Palbociclib Combination as Neoadjuvant Treatment of Stage II-IIIA PAM 50 ROR-defined Low or Intermediate Risk Luminal Breast Cancer, in Postmenopausal Women
Sponsor:
UNICANCER
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
NeoPal - UC-0140/1404
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None